Table 5.
Product Name | Manufacturer | Reference Product | Molecule | Approvals |
---|---|---|---|---|
Follow-on biologic/biosimilar insulins | ||||
Basaglar®, Abasaglar® | Eli Lilly | Lantus® | Insulin glargine | FDA 2015; EMU 2014 |
Basalin® | Gan & Lee | Lantus® | Insulin glargine | China 2005 |
Semglee® | Biocon/Mylan | Lantus® | Insulin glargine | FDA under review; EU, Australia 2018 |
Admelog® | Sanofi | Humalog® | Insulin lispro | FDA 2017 |